These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20469618)

  • 1. TORCH study results: pharmacotherapy reduces lung function decline in patients with chronic obstructive pulmonary disease.
    McDonough C; Blanchard AR
    Hosp Pract (1995); 2010 Apr; 38(2):92-3. PubMed ID: 20469618
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.
    Celli BR; Thomas NE; Anderson JA; Ferguson GT; Jenkins CR; Jones PW; Vestbo J; Knobil K; Yates JC; Calverley PM
    Am J Respir Crit Care Med; 2008 Aug; 178(4):332-8. PubMed ID: 18511702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summaries for patients. Effect of treatment with fluticasone with and without salmeterol on airway inflammation and lung function in patients with chronic obstructive pulmonary disease: a randomized trial.
    Ann Intern Med; 2009 Oct; 151(8):I21. PubMed ID: 19841438
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bronchodilator efficacy of combined salmeterol and tiotropium in patients with chronic obstructive pulmonary disease].
    Baloira Villar A; Vilariño Pombo C
    Arch Bronconeumol; 2005 Mar; 41(3):130-4. PubMed ID: 15766465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial.
    Lapperre TS; Snoeck-Stroband JB; Gosman MM; Jansen DF; van Schadewijk A; Thiadens HA; Vonk JM; Boezen HM; Ten Hacken NH; Sont JK; Rabe KF; Kerstjens HA; Hiemstra PS; Timens W; Postma DS; Sterk PJ;
    Ann Intern Med; 2009 Oct; 151(8):517-27. PubMed ID: 19841453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhalation combination therapy in chronic obstructive lung disease. TRISTAN-study].
    Seeger W; Schulz R
    Internist (Berl); 2004 Jun; 45(6):727-8. PubMed ID: 15138641
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined salmeterol and fluticasone for COPD.
    Vassiliou V
    Lancet; 2003 May; 361(9369):1651; author reply 1652-3. PubMed ID: 12747901
    [No Abstract]   [Full Text] [Related]  

  • 8. The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.
    Zheng JP; Yang L; Wu YM; Chen P; Wen ZG; Huang WJ; Shi Y; Wang CZ; Huang SG; Sun TY; Wang GF; Xiong SD; Zhong NS
    Chest; 2007 Dec; 132(6):1756-63. PubMed ID: 17951625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal of inhaled glucocorticoids and exacerbations of COPD.
    Magnussen H; Disse B; Rodriguez-Roisin R; Kirsten A; Watz H; Tetzlaff K; Towse L; Finnigan H; Dahl R; Decramer M; Chanez P; Wouters EF; Calverley PM;
    N Engl J Med; 2014 Oct; 371(14):1285-94. PubMed ID: 25196117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medications to modify lung function decline in chronic obstructive pulmonary disease: some hopeful signs.
    Suissa S
    Am J Respir Crit Care Med; 2008 Aug; 178(4):322-3. PubMed ID: 18676961
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
    Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
    Lung; 2006; 184(4):217-22. PubMed ID: 17006748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pharmacotherapy on rate of decline of FEV(1) in the TORCH study.
    Marchand E
    Am J Respir Crit Care Med; 2009 Mar; 179(5):426; author reply 426-7. PubMed ID: 19234322
    [No Abstract]   [Full Text] [Related]  

  • 13. [Impact of COPD therapy on patient survival: the TORCH Study (TOwards a Revolution in COPD Health)].
    Nitschmann S; Schultze-Werninghaus G
    Internist (Berl); 2007 Dec; 48(12):1450-2. PubMed ID: 17965844
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in COPD patients after regular use of fluticasone propionate and salmeterol.
    Marchand E
    Eur Respir J; 2003 Mar; 21(3):559-60; author reply 560. PubMed ID: 12662020
    [No Abstract]   [Full Text] [Related]  

  • 16. Parasternal muscle activity decreases in severe COPD with salmeterol-fluticasone propionate.
    Easton PA; Hawes HG; Doig CJ; Johnson MW; Yokoba M; Wilde ER
    Chest; 2010 Mar; 137(3):558-65. PubMed ID: 19820074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.
    Donohue JF; Kalberg C; Emmett A; Merchant K; Knobil K
    Treat Respir Med; 2004; 3(3):173-81. PubMed ID: 15219176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.
    Vestbo J; Pauwels R; Anderson JA; Jones P; Calverley P;
    Thorax; 2005 Apr; 60(4):301-4. PubMed ID: 15790985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes.
    Anzueto A; Ferguson GT; Feldman G; Chinsky K; Seibert A; Emmett A; Knobil K; O'Dell D; Kalberg C; Crater G
    COPD; 2009 Oct; 6(5):320-9. PubMed ID: 19863361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TORCH (towards a revolution in COPD health) survival study protocol.
    Vestbo J;
    Eur Respir J; 2004 Aug; 24(2):206-10. PubMed ID: 15332386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.